← Browse by Condition
Medical Condition

msihi or dmmr advanced unresectable or metastatic solid tumors including colorectal cancers

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT07003022 Phase 2
Recruiting

Phase Ⅱ Clinical Trial of Cadonilimab Combined With Anti-angiogenic Agents in Metastatic dMMR/MSI-H CRC

Enrollment
40 pts
Location
China
Sponsor
Fudan University
View Trial →